GTS Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-103,600
Closed -$91.8M 2835
2024
Q3
$91.8M Buy
103,600
+12,200
+13% +$11M 0.2% 54
2024
Q2
$82.8M Sell
91,400
-2,300
-2% -$1.84M 0.18% 55
2024
Q1
$72.9M Buy
93,700
+10,700
+13% +$7.61M 0.13% 66
2023
Q4
$48.4M Sell
83,000
-2,700
-3% -$1.58M 0.08% 130
2023
Q3
$46M Buy
+85,700
New +$44.2M 0.08% 128

Other funds holding LLY

GTS Securities's LLY Position: Q1 2026 in Review

GTS Securities reduced its Eli Lilly (LLY) stake by 54% in Q1 2026, selling an estimated $4.49M and leaving 3,719 shares worth $3.42M. The position accounts for 0.12% of the portfolio, ranked #112.

GTS Securities first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $14.7M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GTS Securities held 3,719 shares of Eli Lilly worth $3.42M as of Q1 2026.
  • GTS Securities sold 4,427 Eli Lilly shares in Q1 2026, an estimated $4.49M.
  • Eli Lilly made up 0.12% of GTS Securities's portfolio in Q1 2026, its #112 holding.
  • GTS Securities first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Eli Lilly position peaked at $14.7M in Q3 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.